Vector Copy number (VCN) digital PCR kit & testing for cell and gene therapy QC

VCN refers to the number of vector copies integrated into the DNA of a host cell. It’s a crucial parameter in gene therapy and cell engineering, such as CAR-T therapy where viral vectors are used to introduce new genetic material. VCN is important for monitoring transgene expression, optimizing viral dose, and ensuring consistent therapeutic outcomes. However, a high VCN can also increase the risk of insertional mutagenesis and oncogenesis, making it a critical safety parameter.

Digital PCR counts target molecules directly using Poisson statistics — partitioning a sample into thousands of independent reactions, then tallying how many partitions contain the target. For vector copy number, that means absolute quantification of WPRE (or your vector-specific target) per genome equivalent, with no standard curve and no relative-quantification approximation.

Cross-batch and cross-lab comparability: dPCR removes standard-curve variability, so VCN values measured today are directly comparable to results from a different lot, a different operator, or a different site. Critical for GMP release testing, regulatory submissions, and longitudinal process monitoring.

Precision at low copy numbers: where qPCR begins to lose resolution (typically below ~2-fold differences), dPCR can resolve VCN differences within ~10% — meaningful when your release spec sits between 1 and 5 copies per cell.

Inhibitor tolerance: integrated-vector samples often carry residual extraction inhibitors. dPCR’s endpoint detection is more robust to inhibitors than real-time PCR, reducing failed runs and re-extractions.

AAV viral titer as a related application: dPCR is widely considered the gold standard for AAV titer measurement, so a lab adopting dPCR for VCN can typically extend the same platform to upstream titer QC without adding instruments.